Lab testing transparency will improve patient care and lower costs

The require for comprehensible and clear pricing for healthcare services in the U.S. has improved in urgency with the continuing increase of out-of-pocket healthcare prices.

Individuals are delaying health care mainly because they are unsure of the value or they can’t manage it. A latest Willis Tower Watson (WTW) survey of 9,600 U.S. employees showed that 4 in 10 people deferred health care in the previous yr, with 28% delaying or canceling a health-related course of action and 17% not filling a prescription.

Latest federal mandates are inching rate transparency forward with the objective of improving upon care when reducing

  Read more

Genetic testing for hereditary GI cancers goes beyond individual patient care

Molos reports no relevant financial disclosures.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]

In this Healio video exclusive, Mark A. Molos, MD, of WestGlen Gastrointestinal Consultants in Shawnee, Kansas, discusses his experience with the GI OnDEMAND genetic testing program from Ambry Genetics.

According to Molos, the

  Read more